30 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/30/2872179/0/en/Eagle-Pharmaceuticals-Announces-a-Trial-in-Progress-Presentation-of-Phase-2-3-Study-of-Intravenous-Amisulpride-as-Prevention-of-Postoperative-Nausea-and-Vomiting-in-Pediatric-Patie.html
15 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/15/2862631/0/en/Eagle-Pharmaceuticals-to-Present-Additional-Data-from-Phase-III-Trial-Demonstrating-Sustained-Response-of-Amisulpride-for-the-Rescue-Treatment-of-Postoperative-Nausea-and-Vomiting-.html
06 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/12/06/2792093/0/en/Eagle-Pharmaceuticals-to-Present-Abstract-on-Post-hoc-Analysis-of-Amisulpride-at-the-77th-PGA-PostGraduate-Assembly-in-Anesthesiology-in-New-York-City.html
09 Feb 2022
// BUSINESSWIRE
07 Dec 2021
// BUSINESSWIRE
29 Sep 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/09/29/2305003/0/en/Acacia-Pharma-Announces-Submission-and-Validation-of-Marketing-Authorization-Application-for-BARHEMSYS-amisulpride-injection-in-Major-European-Markets.html
LOOKING FOR A SUPPLIER?